High-Profile Trial Suspensions Due to Audit Findings: What Went Wrong
High-Profile Trial Suspensions Due to Audit Findings: What Went Wrong High-Profile Clinical Trial Suspensions Caused by Audit Findings Introduction: When Audit Findings Halt Clinical Development Regulatory audits play a crucial role in ensuring that clinical trials comply with ICH GCP and national legislation. In some cases, deficiencies are so significant that regulators suspend or place…
Read More “High-Profile Trial Suspensions Due to Audit Findings: What Went Wrong” »